IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q2 FY21 results · Jul–Sep 2020
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹533.48 crore (up 18.8% from Q2 FY20) and net profit of ₹126.96 crore (up 44.8% from Q2 FY20) for Q2 FY21 (Jul–Sep 2020), on a standalone basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 533.48 | 448.96 | +18.8% | 460.11 | +15.9% |
| Other income | 4.48 | 3.39 | +32.2% | 5.80 | −22.8% |
| Total income | 537.96 | 452.35 | +18.9% | 465.91 | +15.5% |
| Profit before tax | 165.05 | 121.38 | +36.0% | 146.74 | +12.5% |
| Net profit for the period | 126.96 | 87.70 | +44.8% | 127.54 | −0.5% |
| EPS, basic (₹) | 21.61 | 15.42 | +40.1% | 22.30 | −3.1% |
| Net margin (%) | 23.8 | 19.5 | 27.7 |
Standalone
- Filed with BSE
- 10 Nov 2020, 12:15 IST
- Board meeting
- 06 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Audited
- Source
- XBRL filing on BSE